AVGO
20
-5
M
20
-4
IP
70
2
ABT
57
-5
FOXA
55
9
JNPR
46
3
QRVO
6
2
HPE
55
11
AZO
46
-3
EQIX
60
-2
PBI
60
-5
PPL
54
2
MDLZ
34
2
TDC
75
4
DHI
48
3
PCG
93
2
DE
46
3
IPG
49
10
DTE
50
3
NRG
49
-3
AVGO
20
-5
M
20
-4
IP
70
2
ABT
57
-5
FOXA
55
9
JNPR
46
3
QRVO
6
2
HPE
55
11
AZO
46
-3
EQIX
60
-2
PBI
60
-5
PPL
54
2
MDLZ
34
2
TDC
75
4
DHI
48
3
PCG
93
2
DE
46
3
IPG
49
10
DTE
50
3
NRG
49
-3
Financhill
Back

Adaptimmune Therapeutics PLC Vs. NuCana PLC Industry Stock Comparison

Sell
20

ADAP
Adaptimmune Therapeutics PLC

Last Price:
0.63
Seasonality Move:
50.57%
Buy
60

NCNA
NuCana PLC

Last Price:
1.27
Seasonality Move:
11.81%
Sell
20
Adaptimmune Therapeutics PLC (ADAP) is a Sell

Is Adaptimmune Therapeutics PLC a Buy, Sell or Hold?

  • The current Adaptimmune Therapeutics PLC [ADAP] share price is $0.64. The Score for ADAP is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
  • ADAP is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
60
NuCana PLC (NCNA) is a Buy

Is NuCana PLC a Buy, Sell or Hold?

  • The current NuCana PLC [NCNA] share price is $1.28. The Score for NCNA is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
  • NCNA is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

ADAP Stock Price Chart

What is Adaptimmune Therapeutics PLC's stock price today?

  • The Adaptimmune Therapeutics PLC share price today is $0.64
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ADAP is experiencing selling pressure, which indicates risk of future bearish movement.

NCNA Stock Price Chart

What is NuCana PLC's stock price today?

  • The NuCana PLC share price today is $1.28
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NCNA is experiencing slight buying pressure.

ADAP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.06 Sell
Relative Strength Index (14 RSI): 36.24 Sell
Chaikin Money Flow: -608296 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.66 - 0.82) Sell
Bollinger Bands (100): (0.81 - 1.21) Sell

NCNA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.23 Sell
Relative Strength Index (14 RSI): 28 Sell
Chaikin Money Flow: -69618 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

ADAP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.66 Sell
20-day SMA: 0.73 Sell
50-day SMA: 0.85 Sell
200-day SMA: 1.12 Sell
8-day EMA: 0.67 Sell
20-day EMA: 0.73 Sell
50-day EMA: 0.83 Sell
200-day EMA: 1 Sell

NCNA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.48 Sell
20-day SMA: 1.57 Sell
50-day SMA: 2.16 Sell
200-day SMA: 4.3 Sell
8-day EMA: 1.44 Sell
20-day EMA: 1.61 Sell
50-day EMA: 2.18 Sell
200-day EMA: 5 Sell

Adaptimmune Therapeutics PLC Earnings Growth & ADAP Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.36 per share, and a decrease next year of $0.33 per share.

NuCana PLC Earnings Growth & NCNA Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.56 per share, and an increase next year of $0.19 per share.

Adaptimmune Therapeutics PLC Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

NuCana PLC Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):